Plain-English translation of NCT06600529 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a combination of three treatments for children with autism spectrum disorder: laser light therapy applied at acupuncture points, platelet-rich plasma (a concentration of healing cells from your own blood), and exosomes (tiny cellular particles derived from umbilical cord tissue). The study will compare children who receive these new treatments alongside standard autism therapy to children who receive standard therapy alone, measuring changes in autism symptoms over 6 months.
Researchers are exploring whether these three treatments—when combined—might help improve symptoms and outcomes for children with autism beyond what current standard care alone can offer. The goal is to see if this new approach provides additional benefit for families seeking more options.
You likely qualify if…
You likely don't qualify if…
If you are in the treatment group, you would receive laser light therapy once a week at specific points on your body, along with infusions of your own platelet-rich plasma at weeks 0, 2, 4, and 6, and then receive umbilical cord cell extract injections at several timepoints over 6 months. You would also continue your regular autism therapy. Throughout the 6-month study, your child will have regular visits for assessments and follow-up care to measure any changes in autism symptoms.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Pakistan